Clinical trial
D2E7-Early AS
NCT00235105 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00235105 |
|---|---|
| Title | D2E7-Early AS |
| Official title | Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | Abbott Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | Adalimumab 40 mg sc every other week |
| Enrollment | 46 |
| Start date | Mar 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Oct 10, 2005 |
| Last update posted | Dec 9, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: